Search Results - "Walisser, Susan"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model by Moldaver, Daniel, Hurry, Manjusha, Evans, William K., Cheema, Parneet K., Sangha, Randeep, Burkes, Ronald, Melosky, Barbara, Tran, Diana, Boehm, Darryl, Venkatesh, Jaya, Walisser, Susan, Orava, Erik, Grima, Daniel

    Published in Lung cancer (Amsterdam, Netherlands) (01-01-2020)
    “…•Rapid changes in lung cancer treatment can cause budgetary issues.•The iTEN model was built to assess the impact of new lung cancer therapies.•The model…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation by de Lemos, Mário L, Markarian, Adeline, Chan, Esther, Schaff, Kimberly, Walisser, Susan

    Published in Journal of Oncology Pharmacy Practice (01-01-2018)
    “…Background Bevacizumab is an antiangiogenic agent active in patients with recurrent malignant gliomas. However, evidence for its clinical efficacy is…”
    Get full text
    Book Review Journal Article
  5. 5

    Adherence with capecitabine: A population-based analysis based on prescription refill data by Kovacic, Laurel, de Haan, Neil, de Lemos, Mário L, Schaff, Kimberly, Walisser, Susan

    Published in Journal of oncology pharmacy practice (01-06-2017)
    “…Background Patient adherence is important with the increasing use of oral anticancer drugs. Recent studies reported different capecitabine adherence rates…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Characteristics of patients at risk for adverse drug events: designing for patient safety and decision support by Borycki, Elizabeth, Barnett, Jeff, Walisser, Susan, Bellwood, Paule, Clarke, Melissa, Greig, David

    “…Adverse drug events are a significant global health issue. In this paper we describe our research work to date in identifying the characteristics of patients…”
    Get more information
    Journal Article
  8. 8

    Management of extravasation of oxaliplatin by de Lemos, Mário L, Walisser, Susan

    Published in Journal of oncology pharmacy practice (01-12-2005)
    “…Oxaliplatin extravasation has been associated with local pain and inflammation which may be severe and lead to complications including necrosis. Recent case…”
    Get full text
    Journal Article